Apellis Pharmaceuticals, Inc. (APLS)

Apellis Pharmaceuticals Stock Forecast

Stock Price Forecast

The 19 analysts that cover Apellis Pharmaceuticals stock have a consensus rating of "Buy" and an average price target of $33.58, which forecasts a 68.41% increase in the stock price over the next year. The lowest target is $18 and the highest is $52.

Price Target: $33.58 (+68.41%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$18	$33.58	$32	$52
Change	-9.73%	+68.41%	+60.48%	+160.78%

Analyst Ratings

The average analyst rating for Apellis Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Aug '25	Sep '25	Oct '25	Nov '25	Dec '25	Jan '26
Strong Buy	3	3	4	4	5	5
Buy	7	7	7	7	6	6
Hold	10	9	8	9	8	8
Sell	0	0	0	0	0	0
Strong Sell	0	1	1	1	1	1
Total	20	20	20	21	20	20

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Steve Seedhouse Cantor Fitzgerald	Cantor Fitzgerald	Buy Maintains $39 → $35	Buy	Maintains	$39 → $35	+75.53%	Jan 13, 2026
Joseph Stringer Needham	Needham	Strong Buy Maintains $29 → $28	Strong Buy	Maintains	$29 → $28	+40.42%	Jan 13, 2026
Annabel Samimy Stifel	Stifel	Strong Buy Maintains $55 → $48	Strong Buy	Maintains	$55 → $48	+140.72%	Dec 19, 2025
Andy Chen Wolfe Research	Wolfe Research	Hold Initiates n/a	Hold	Initiates	n/a	n/a	Nov 6, 2025
Anupam Rama JP Morgan	JP Morgan	Buy Maintains $40 → $36	Buy	Maintains	$40 → $36	+80.54%	Nov 5, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

1.01B

Increased by 28.88%

from 781.37M

Revenue Next Year

885.99M

Decreased by -12.02%

from 1.01B

EPS This Year

0.25

from -1.60

EPS Next Year

-1.11

from 0.25

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	250.65M	66.56M	75.42M	396.59M	781.37M	1.01B	885.99M
Revenue Growth	-	-73.44%	13.31%	425.83%	97.02%	28.88%	-12.02%
EPS	-4.59	-8.84	-6.15	-4.45	-1.60	0.25	-1.11
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	81.21	-
No. Analysts	-	-	-	-	-	21	21

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029	2030
High	1.1B	1.0B
Avg	1.0B	886.0M
Low	684.3M	771.9M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029	2030
High	41.2%	-0.4%
Avg	28.9%	-12.0%
Low	-12.4%	-23.3%

EPS Forecast

EPS	2025	2026	2027	2028	2029	2030
High	0.50	0.44
Avg	0.25	-1.11
Low	0.13	-1.70

EPS Growth

EPS Growth	2025	2026	2027	2028	2029	2030
High	-	80.5%
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.